BioAtla Statistics

Total Valuation

BioAtla has a market cap or net worth of $6.11 million. The enterprise value is $10.24 million.

Market Cap	6.11M
Enterprise Value	10.24M

Important Dates

The next estimated earnings date is Thursday, August 6, 2026, after market close.

Earnings Date	Aug 6, 2026
Ex-Dividend Date	n/a

Share Statistics

BioAtla has 1.66 million shares outstanding. The number of shares has increased by 23.33% in one year.

Current Share Class	1.66M
Shares Outstanding	1.66M
Shares Change (YoY)	+23.33%
Shares Change (QoQ)	+25.56%
Owned by Insiders (%)	7.52%
Owned by Institutions (%)	14.07%
Float	1.37M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3.05
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	5.12
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.15

Current Ratio	0.15
Quick Ratio	0.09
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-133.12%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	411.50%
Weighted Average Cost of Capital (WACC)	4.25%
Revenue Per Employee	$48,780
Profits Per Employee	-$1.23M
Employee Count	41
Asset Turnover	0.09
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -81.88% in the last 52 weeks. The beta is 0.77, so BioAtla's price volatility has been lower than the market average.

Beta (5Y)	0.77
52-Week Price Change	-81.88%
50-Day Moving Average	4.10
200-Day Moving Average	19.92
Relative Strength Index (RSI)	47.40
Average Volume (20 Days)	67,170

Short Selling Information

The latest short interest is 147,632, so 8.90% of the outstanding shares have been sold short.

Short Interest	147,632
Short Previous Month	162,567
Short % of Shares Out	8.90%
Short % of Float	10.77%
Short Ratio (days to cover)	4.35

Income Statement

In the last 12 months, BioAtla had revenue of $2.00 million and -$50.62 million in losses. Loss per share was -$40.15.

Revenue	2.00M
Gross Profit	-32.90M
Operating Income	-49.90M
Pretax Income	-50.62M
Net Income	-50.62M
EBITDA	-49.59M
EBIT	-49.90M
Loss Per Share	-$40.15

Full Income Statement

Balance Sheet

The company has $1.96 million in cash and $6.09 million in debt, giving a net cash position of -$4.13 million or -$2.49 per share.

Cash & Cash Equivalents	1.96M
Total Debt	6.09M
Net Cash	-4.13M
Net Cash Per Share	-$2.49
Equity (Book Value)	-37.31M
Book Value Per Share	-22.48
Working Capital	-17.60M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-37.18M
Capital Expenditures	n/a
Depreciation & Amortization	310,000
Net Borrowing	7.13M
Free Cash Flow	-37.18M
FCF Per Share	-$22.40

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-2,494.95%
Pretax Margin	-2,530.85%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BioAtla does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-23.33%
Shareholder Yield	-23.33%
Earnings Yield	-828.79%
FCF Yield	-608.82%

Analyst Forecast

The average price target for BioAtla is $500.00, which is 13,486.96% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$500.00
Price Target Difference	13,486.96%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (3Y)	n/a
EPS Growth Forecast (3Y)	n/a

Stock Splits

The last stock split was on April 6, 2026. It was a reverse split with a ratio of 1:50.

Last Split Date	Apr 6, 2026
Split Type	Reverse
Split Ratio	1:50

Scores

BioAtla has an Altman Z-Score of -111.3 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-111.3
Piotroski F-Score	1